JOP20180017A1 - مثبط كيناز منظم لإشارة تلاشي خلايا - Google Patents
مثبط كيناز منظم لإشارة تلاشي خلاياInfo
- Publication number
- JOP20180017A1 JOP20180017A1 JOP/2018/0017A JOP20180017A JOP20180017A1 JO P20180017 A1 JOP20180017 A1 JO P20180017A1 JO P20180017 A JOP20180017 A JO P20180017A JO P20180017 A1 JOP20180017 A1 JO P20180017A1
- Authority
- JO
- Jordan
- Prior art keywords
- kinase inhibitor
- apoptosis signal
- regulating kinase
- compound
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
يتعلق الاختراع الحالي بتوفير مركب بالصيغة (I) (I)؛ أو ملح مقبول صيدليًا منه للاستخدام في علاج التهاب الكبد الدهني غير المرتبط بالكحول، التهاب الكبد المرتبط بالكحول، ارتفاع ضغط الدم الشرياني الرئوي، قصور القلب مع الكَسْرُ القَذْفِيّ المحفوظ، وداء الكلى الناتج عن مرض السكر. كذلك يتم توفير صور غير متبلّرة ومتبلّرة من المركب بالصيغة (I) وأملاح، بلورات مشتركة، ذوّابات، ومركبات هيدرات منه.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762471300P | 2017-03-14 | 2017-03-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
JOP20180017A1 true JOP20180017A1 (ar) | 2019-01-30 |
Family
ID=61750538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2018/0017A JOP20180017A1 (ar) | 2017-03-14 | 2017-03-14 | مثبط كيناز منظم لإشارة تلاشي خلايا |
Country Status (6)
Country | Link |
---|---|
AR (1) | AR111178A1 (ar) |
BR (1) | BR102018004862A2 (ar) |
JO (1) | JOP20180017A1 (ar) |
TW (1) | TW201840551A (ar) |
UY (1) | UY37631A (ar) |
WO (1) | WO2018169742A1 (ar) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI625121B (zh) | 2009-07-13 | 2018-06-01 | 基利科學股份有限公司 | 調節細胞凋亡信號之激酶的抑制劑 |
AU2018266911C1 (en) | 2017-05-12 | 2022-10-20 | Enanta Pharmaceuticals, Inc. | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof |
US10597382B2 (en) | 2017-08-28 | 2020-03-24 | Enanta Pharmaceuticals, Inc. | Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof |
WO2019213239A1 (en) | 2018-05-02 | 2019-11-07 | Enanta Pharmaceuticals Inc. | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof |
JP7328254B2 (ja) | 2018-05-02 | 2023-08-16 | エナンタ ファーマシューティカルズ インコーポレイテッド | アポトーシスシグナル調節キナーゼ1阻害剤を含むテトラゾール及びその使用方法 |
CN110818683B (zh) * | 2018-08-10 | 2023-04-14 | 中国科学院上海药物研究所 | 2-吡啶取代脲结构小分子化合物及其合成和应用 |
WO2020041417A1 (en) | 2018-08-22 | 2020-02-27 | Enanta Pharmaceuticals, Inc. | Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof |
WO2020106707A1 (en) | 2018-11-19 | 2020-05-28 | Enanta Pharmaceuticals, Inc. | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof |
WO2020198214A1 (en) | 2019-03-25 | 2020-10-01 | Enanta Pharmaceuticals, Inc. | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof |
WO2023125904A1 (zh) * | 2021-12-30 | 2023-07-06 | 苏州晶云药物科技股份有限公司 | 氮杂环丁基烟酸类化合物的晶型及其制备方法 |
CN117503932A (zh) * | 2022-07-30 | 2024-02-06 | 中国医学科学院阜外医院 | Jun抑制剂在制备用于治疗射血分数保留的心衰的药物中的用途 |
CN117054652B (zh) * | 2023-08-04 | 2024-05-17 | 南京医科大学 | 一种用于辅助检测心肌肥厚的生物标志物及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI625121B (zh) | 2009-07-13 | 2018-06-01 | 基利科學股份有限公司 | 調節細胞凋亡信號之激酶的抑制劑 |
EP2545964A1 (en) | 2011-07-13 | 2013-01-16 | Phenex Pharmaceuticals AG | Novel FXR (NR1H4) binding and activity modulating compounds |
UY34573A (es) | 2012-01-27 | 2013-06-28 | Gilead Sciences Inc | Inhibidor de la quinasa que regula la señal de la apoptosis |
WO2015187499A1 (en) | 2014-06-03 | 2015-12-10 | Gilead Sciences, Inc. | Use of an ask1 inhibitor for the treatment of liver disease, optionally in combination with a loxl2 inhibitor |
TW201618781A (zh) | 2014-08-13 | 2016-06-01 | 吉李德科學股份有限公司 | 治療肺高血壓之方法 |
MA41252A (fr) * | 2014-12-23 | 2017-10-31 | Gilead Sciences Inc | Formes solides d'un inhibiteur d'ask 1 |
-
2017
- 2017-03-14 JO JOP/2018/0017A patent/JOP20180017A1/ar unknown
-
2018
- 2018-03-07 WO PCT/US2018/021334 patent/WO2018169742A1/en active Application Filing
- 2018-03-12 BR BR102018004862A patent/BR102018004862A2/pt not_active Application Discontinuation
- 2018-03-13 TW TW107108465A patent/TW201840551A/zh unknown
- 2018-03-14 AR ARP180100585A patent/AR111178A1/es unknown
- 2018-03-14 UY UY0001037631A patent/UY37631A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR111178A1 (es) | 2019-06-12 |
BR102018004862A2 (pt) | 2019-01-02 |
UY37631A (es) | 2018-09-28 |
WO2018169742A1 (en) | 2018-09-20 |
TW201840551A (zh) | 2018-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JOP20180017A1 (ar) | مثبط كيناز منظم لإشارة تلاشي خلايا | |
AR106237A2 (es) | Inhibidores heterocíclicos de la aspartil proteasa, sus sales farmacéuticamente aceptables | |
PH12020551090A1 (en) | Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors | |
AR105238A1 (es) | Compuestos de benzoxacepina oxazolidinona y métodos de uso | |
NZ758345A (en) | Ask1 inhibitor compounds and uses thereof | |
NZ739339A (en) | Apoptosis signal-regulating kinase inhibitor | |
MA38078A1 (fr) | Dérivé de pyridine | |
BR112015031864A2 (pt) | compostos de pirimidinadiona contra as condições cardíacas | |
RS54030B1 (en) | PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR CANCER TREATMENT | |
EA200802329A1 (ru) | Производные триазола ii | |
WO2009016460A8 (en) | Pyrazole compounds and their use as raf inhibitors | |
UA106611C2 (uk) | Інгібітори зовнішнього медулярного калієвого каналу нирок | |
PH12018500261B1 (en) | Azole benzene derivative | |
EA201000007A1 (ru) | Производные индазоламида | |
ECSP12012048A (es) | Antagonistas del receptor mineralcorticoide no esteroidal | |
WO2013072921A3 (en) | Process for preparation of substituted 3'-hydrazino-biphenyl-3-carboxylic acid compounds | |
MX2019013626A (es) | Modo de accion dual novedoso de activadores de guanilato ciclasa solubles e inhibidores de fosfodiesterasa y usos de los mismos. | |
EA200900913A1 (ru) | Производное триазола в качестве ингибитора hsp90 | |
BR112018075206A2 (pt) | tratamento de malignidade hematológica com 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolin-5-il)metil)-2,2-difluoroacetamida | |
ZA202307945B (en) | Pyridopyrimidinone derivative, preparation method therefor, and use thereof | |
CR20140462A (es) | Sales de 5-[(1r)-2-({2-[4-(2,2-difluoro-2-feniletoxi)fenil]etil} amino) -1-hidroxietil]-8-hidroquinolin-2(1h)-ona | |
PH12021550449A1 (en) | 2,6-diamino pyridine compounds. | |
ZA202100352B (en) | Novel 3, 5-disubstituted pyridine and 3, 5-disubstituted pyridazine derivatives and pharmaceutical use of same | |
JOP20210329A1 (ar) | مركبات بيرازول مزدوجة الاستبدال كمثبطات كيتو هيكسو كيناز | |
AR117920A1 (es) | Inhibidores de la replicación del virus de la inmunodeficiencia humana |